ADC Biotechnology Revenue and Competitors
Estimated Revenue & Valuation
- ADC Biotechnology's estimated annual revenue is currently $1.9M per year.
- ADC Biotechnology's estimated revenue per employee is $155,000
Employee Data
- ADC Biotechnology has 12 Employees.
- ADC Biotechnology grew their employee count by -20% last year.
ADC Biotechnology's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head Quality Control | Reveal Email/Phone |
2 | Head Technical Services | Reveal Email/Phone |
3 | Development Scientist | Reveal Email/Phone |
4 | Microbiologist | Reveal Email/Phone |
5 | Team Leader | Reveal Email/Phone |
6 | QC Analyst | Reveal Email/Phone |
ADC Biotechnology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is ADC Biotechnology?
ADC Biotechnology Ltd was founded in 2010 to develop and commercialise next generation conjugation technologies to the Antibody Drug Conjugate market. Bioconjugation using our proprietary 'Lock-Release' technology involves conjugation of proteins that are immobilised on solid supports, which delivers a number of key product advantages from minimal aggregate formation to minimal residual free drug and enhanced yields. From basic R&D applications through to improved supply economics and product risk management application of our 'Lock-Release' platform drives value through better products delivered with greater efficiency. In addition to technology development, ADC Biotechnology offers a range of technical services, including conjugation (conventional and Lock-Release) to a variety of toxin payloads, toxin-linker design and synthesis and supply of ADCs for proof of concept and toxicology testing. For more information on our services and Lock Release please visit www.adcbio.com
keywords:N/A
N/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ADC Biotechnology News
Sterling's Deeside facility was part of its acquisition of ADC Biotechnology, which broadened the company's small molecule drug development...
Other Companies in Deeside
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.1M | 55 | -2% | N/A |
#2 | N/A | 56 | 22% | N/A |
#3 | $6.8M | 75 | -29% | N/A |
#4 | $11.8M | 76 | 9% | N/A |
#5 | $27M | 93 | 3% | N/A |